Sigyn Therapeutics (SIGY) Invested Capital (2024 - 2025)
Sigyn Therapeutics (SIGY) posted Invested Capital of $304637.0 for Q3 2025, up 16.25% sequentially from $262062.0 in Q2 2025.
Sigyn Therapeutics (SIGY) Invested Capital (2024 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Invested Capital for 2 years, with the latest figure at $304637.0 in Q3 2025.
- Quarterly Invested Capital changed N/A year-over-year to $304637.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $953825.0 (changed N/A YoY) and the FY2024 annual result came in at $174206.0, changed N/A from the prior year.
- Invested Capital advanced to $304637.0 in Q3 2025 per SIGY's latest filing, from $262062.0 in the prior quarter.
- Over five years, Invested Capital peaked at $304637.0 in Q3 2025 and troughed at $174206.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 304,637.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 304,637.00 |
| Jun 30, 2025 | 262,062.00 |
| Mar 31, 2025 | 212,920.00 |
| Dec 31, 2024 | 174,206.00 |